Do not re-use or share needles with other people
Results: As of 8-Jan-2025, 292 of the target 302 subjects were randomized: mean age 57.513 years, female 117 (40.1%), from Philippines 269 (92.1%), received revascularization therapy 41 (14%), mean baseline NIHSS 11.02.8, mean NIHSS motor score 6.41.8, and mean baseline FMA 25.321.2
Most GLP-1s are only FDA-approved for use in adults
An expert companion for their weight-loss medication journey Your patients will also get access to Noom GLP-1 Companion a personalized curriculum featuring nutrition guidance, a Muscle Defense library of on-demand workout videos to help keep the muscle while they lose fat, protein-tracking tools, and side-effect management resourcesproviding them with extra support every step of the way
In general, telehealth GLP-1 programs prescribe either FDA-approved brand products or compounded semaglutide or tirzepatide, depending on eligibility and the pharmacy pathway a program uses